U.S. Competition Watchdog Decries Drug Deals
While the head of the world’s largest generic pharmaceutical manufacturers testified Wednesday before a senate committee in defense of rival company agreements, the Federal Trade Commission said the deals cheated consumers out of billions of dollars in savings on cheap drugs.
A study released Wednesday by the FTC shows the number of...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login